Prognostic Value of CA 19-9 in a Phase I/II Trial of Dose Escalated Intensity Modulated Radiation Therapy (IMRT) With Concurrent Full-dose Gemcitabine (G) in Unresectable Pancreatic Cancer

被引：0
|
作者：
Vainshtein, J. M. [1 ]
Schipper, M. [1 ]
Zalupski, M. [1 ]
Lawrence, T. S. [1 ]
Abrams, R. [2 ]
Francis, I. R. [1 ]
Leslie, W. [2 ]
Ben-Josef, E. [3 ]
机构：
[1] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[2] Rush Presbyterian St Lukes Med Ctr, Chicago, IL USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S146 / S147
页数：2
相关论文
共 50 条
  • [21] Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety
    Gurka, Marie K.
    Collins, Sean P.
    Slack, Rebecca
    Tse, Gary
    Charabaty, Aline
    Ley, Lisa
    Berzcel, Liam
    Lei, Siyuan
    Suy, Simeng
    Haddad, Nadim
    Jha, Reena
    Johnson, Colin D.
    Jackson, Patrick
    Marshall, John L.
    Pishvaian, Michael J.
    RADIATION ONCOLOGY, 2013, 8
  • [22] Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety
    Marie K Gurka
    Sean P Collins
    Rebecca Slack
    Gary Tse
    Aline Charabaty
    Lisa Ley
    Liam Berzcel
    Siyuan Lei
    Simeng Suy
    Nadim Haddad
    Reena Jha
    Colin D Johnson
    Patrick Jackson
    John L Marshall
    Michael J Pishvaian
    Radiation Oncology, 8
  • [23] Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
    Badiyan, Shahed N.
    Olsen, Jeffrey R.
    Lee, Andrew Y.
    Yano, Motoyo
    Menias, Christine O.
    Khwaja, Shariq
    Wang-Gillam, Andrea
    Strasberg, Steven M.
    Hawkins, William G.
    Linehan, David C.
    Myerson, Robert J.
    Parikh, Parag J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 1 - 7
  • [24] A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma
    Mark S. Talamonti
    William Small
    Mary F. Mulcahy
    Jeffrey D. Wayne
    Vikram Attaluri
    Lisa M. Colletti
    Mark M. Zalupski
    John P. Hoffman
    Gary M. Freedman
    Timothy J. Kinsella
    Philip A. Philip
    Cornelius J. McGinn
    Annals of Surgical Oncology, 2006, 13 : 150 - 158
  • [25] A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma
    Talamonti, MS
    Small, W
    Mulcahy, MF
    Wayne, JD
    Attaluri, V
    Colletti, LM
    Zalupski, MM
    Hoffman, JP
    Freedman, GM
    Kinsella, TJ
    Philip, PA
    McGinn, CJ
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 150 - 158
  • [26] A multicenter randomized phase II study of full-dose gemcitabine and concurrent radiotherapy comparing gemcitabine alone for the unresectable locally advanced pancreatic adenocarcinoma
    Ioka, T.
    Takakura, R.
    Nakaizumi, A.
    Tanaka, S.
    Iishi, H.
    Nakamura, S.
    Nishiyama, K.
    Oohigashi, H.
    Ishikawa, O.
    Watanabe, A.
    Mukai, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Stereotactic Body Radiation Therapy (SBRT) with Concurrent Full-Dose Gemcitabine for Locally Advanced Pancreatic Cancer: A Pilot Trial Demonstrating Safety
    Pishvaian, M. J.
    Slack, R.
    Charabaty, A.
    Ley, L.
    Berzcel, L.
    Nakles, R.
    Jha, R.
    Jackson, P.
    Haddad, N.
    Collins, S. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S339 - S340
  • [28] Quality of life and acute radiation toxicity following hypofractionated stereotactic body radiation therapy with concurrent full-dose gemcitabine for unresectable pancreatic adenocarcinoma
    Gurka, Marie Kate
    Tse, Gary
    Unger, Keith Robert
    Haddad, Nadim G.
    Marshall, John
    Johnson, Colin
    Ley, Lisa
    Slack, Rebecca
    Pishvaian, Michael J.
    Collins, Sean Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [29] Preliminary results of a phase II neoadjuvant trial with gemcitabine/oxaliplatin and cetuximab followed by surgery or concurrent intensity modulated radiation therapy (IMRT) with capecitabine for patients with borderline resectable and unresectable nonmetastatic pancreatic cancer
    Chaudhary, U. B.
    Gudena, V.
    Milling, D. L.
    O'Brien, P.
    Montero, A. J.
    Brashears, J.
    Marshall, D.
    Hoffman, B.
    Garrett-Mayer, E.
    Esnaola, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Prospective Phase I Trial of Concurrent Full Dose Gemcitabine/Nab-paclitaxel and Ablative Radiation Therapy for Borderline and Locally Advanced Pancreatic Cancer
    Kim, H.
    Olsen, J. R.
    Wang-Gillam, A.
    Green, O. L.
    Fields, R. C.
    Hammill, C.
    Strasberg, S.
    Doyle, M. B.
    Hawkins, W.
    Suresh, R.
    Tan, B.
    Pedersen, K.
    Henke, L. E.
    DeWees, T. A.
    Chapman, W.
    Parikh, P. J.
    Roach, M. C., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S209 - S210
12345